메뉴 건너뛰기
Annals of Internal Medicine
Volumn 155, Issue 10, 2011, Pages 722-724
Therapy-related acute myelogenous leukemia in a hydroxyurea-treated patient with sickle cell anemia
Author keywords

[No Author keywords available]
Indexed keywords

CYCLOPHOSPHAMIDE; CYTARABINE; FLUDARABINE; HYDROXYUREA; IDARUBICIN;
EID: 81055137260     PISSN: 00034819     EISSN: 15393704     Source Type: Journal    
DOI: 10.7326/0003-4819-155-10-201111150-00024     Document Type: Letter
Times cited : (13)
References (5)
  • 1
    • 77953057530 scopus 로고    scopus 로고
    • Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia and MSH Patients' Follow-Up. The risks and benefits of long-term use of hydroxyurea in sickle cell anemia: A 17.5 year follow-up
    • [PMID: 20513116]
    • Steinberg MH, McCarthy WF, Castro O, Ballas SK, Armstrong FD, Smith W, et al; Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia and MSH Patients' Follow-Up. The risks and benefits of long-term use of hydroxyurea in sickle cell anemia: A 17.5 year follow-up. Am J Hematol. 2010;85:403-8. [PMID: 20513116]
    • (2010) Am J Hematol , vol.85 , pp. 403-408
    • Steinberg, M.H.1    McCarthy, W.F.2    Castro, O.3    Ballas, S.K.4    Armstrong, F.D.5    Smith, W.6
  • 2
    • 45549105597 scopus 로고    scopus 로고
    • Systematic review: Hydroxyurea for the treatment of adults with sickle cell disease
    • [PMID: 18458272]
    • Lanzkron S, Strouse JJ, Wilson R, Beach MC, Haywood C, Park H, et al. Systematic review: Hydroxyurea for the treatment of adults with sickle cell disease. Ann Intern Med. 2008;148:939-55. [PMID: 18458272]
    • (2008) Ann Intern Med , vol.148 , pp. 939-955
    • Lanzkron, S.1    Strouse, J.J.2    Wilson, R.3    Beach, M.C.4    Haywood, C.5    Park, H.6
  • 3
    • 33745714754 scopus 로고    scopus 로고
    • Long-term incidence of hematological evolution in three French prospective studies of hydroxyurea and pipobroman in polycythemia vera and essential thrombocythemia
    • [PMID: 16810617]
    • Kiladjian JJ, Rain JD, Bernard JF, Briere J, Chomienne C, Fenaux P. Long-term incidence of hematological evolution in three French prospective studies of hydroxyurea and pipobroman in polycythemia vera and essential thrombocythemia. Semin Thromb Hemost. 2006;32:417-21. [PMID: 16810617]
    • (2006) Semin Thromb Hemost , vol.32 , pp. 417-421
    • Kiladjian, J.J.1    Rain, J.D.2    Bernard, J.F.3    Briere, J.4    Chomienne, C.5    Fenaux, P.6
  • 4
    • 0142153285 scopus 로고    scopus 로고
    • Belgian Registry of Sickle Cell Disease patients treated with Hydroxyurea. Malignancies in sickle cell disease patients treated with hydroxyurea [Letter]
    • [PMID: 14531924]
    • Ferster A, Sariban E, Meuleman N; Belgian Registry of Sickle Cell Disease patients treated with Hydroxyurea. Malignancies in sickle cell disease patients treated with hydroxyurea [Letter]. Br J Haematol. 2003;123:368-9. [PMID: 14531924]
    • (2003) Br J Haematol , vol.123 , pp. 368-369
    • Ferster, A.1    Sariban, E.2    Meuleman, N.3
  • 5
    • 70349256226 scopus 로고    scopus 로고
    • The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: Rationale and important changes
    • [PMID: 19357394]
    • Vardiman JW, Thiele J, Arber DA, Brunning RD, Borowitz MJ, Porwit A, et al. The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes. Blood. 2009;114: 937-51. [PMID: 19357394]
    • (2009) Blood , vol.114 , pp. 937-951
    • Vardiman, J.W.1    Thiele, J.2    Arber, D.A.3    Brunning, R.D.4    Borowitz, M.J.5    Porwit, A.6

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.